Compass Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 11/16/2026 | 17.99 M | $18.71 M | 0.00% | 9.63% |
| ORBIMED ADVISORS LLC | 11/16/2026 | 15.22 M | $15.83 M | 0.00% | 8.15% |
| MONTANOVA CAPITAL, LLC | 11/16/2026 | 14.33 M | $14.90 M | 1.60% | 7.67% |
| BLACKROCK, INC. | 11/13/2026 | 11.39 M | $11.85 M | 1.00% | 6.10% |
| ENAVATE SCIENCES GP, LLC | 11/16/2026 | 7.79 M | $8.10 M | 0.00% | 4.17% |
| STATE STREET CORP | 11/12/2026 | 7.74 M | $8.05 M | -22.26% | 4.14% |
| PALO ALTO INVESTORS LP | 11/16/2026 | 7.15 M | $7.43 M | 22.58% | 3.83% |
| VANGUARD CAPITAL MANAGEMENT LLC | 11/13/2026 | 5.99 M | $6.23 M | -2.03% | 3.21% |
| MILLENNIUM MANAGEMENT LLC | 11/16/2026 | 4.69 M | $4.87 M | -0.57% | 2.51% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/13/2026 | 4.17 M | $4.34 M | 13.11% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/06/2026 | 3.64 M | $3.79 M | -4.48% | 1.95% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/16/2026 | 3.52 M | $3.67 M | 0.00% | 1.89% |
| VIVO CAPITAL, LLC | 11/13/2026 | 3.42 M | $3.56 M | -55.87% | 1.83% |
| GOLDMAN SACHS GROUP INC | 11/16/2026 | 3.39 M | $3.53 M | -3.86% | 1.82% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/13/2026 | 3.15 M | $3.28 M | -12.97% | 1.69% |
| HRT FINANCIAL LP | 11/13/2026 | 2.66 M | $2.77 M | 1,465.17% | 1.43% |
| ACADIAN ASSET MANAGEMENT LLC | 11/09/2026 | 2.64 M | $2.73 M | 126.97% | 1.41% |
| CITADEL ADVISORS LLC | 11/16/2026 | 2.14 M | $2.22 M | -40.12% | 1.14% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11/13/2026 | 2.08 M | $2.16 M | -44.90% | 1.11% |
| ALLY BRIDGE GROUP (NY) LLC | 11/16/2026 | 2.00 M | $2.08 M | 100.00% | 1.07% |
| AQR CAPITAL MANAGEMENT LLC | 11/16/2026 | 1.98 M | $2.05 M | -43.71% | 1.06% |
| FISHER ASSET MANAGEMENT, LLC | 11/06/2026 | 1.95 M | $2.02 M | 39.80% | 1.04% |
| FMR LLC | 11/10/2026 | 1.80 M | $1.87 M | 48.27% | 0.96% |
| D. E. SHAW & CO., INC. | 11/16/2026 | 1.75 M | $1.82 M | 753.98% | 0.93% |
| MARSHALL WACE, LLP | 11/13/2026 | 1.71 M | $1.78 M | 409.82% | 0.91% |
| BIRCHVIEW CAPITAL, LP | 11/13/2026 | 1.58 M | $1.64 M | -5.97% | 0.84% |
| MORGAN STANLEY | 11/13/2026 | 1.49 M | $1.55 M | 103.30% | 0.80% |
| ALGERT GLOBAL LLC | 11/17/2026 | 1.46 M | $1.52 M | 373.30% | 0.78% |
| SQUAREPOINT OPS LLC | 11/09/2026 | 1.39 M | $1.45 M | 37.94% | 0.74% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2026 | 1.21 M | $1.26 M | 100.00% | 0.65% |
| NORTHERN TRUST CORP | 11/16/2026 | 1.09 M | $1.13 M | -4.53% | 0.58% |
| CAPTION MANAGEMENT, LLC | 11/16/2026 | 1.00 M | $1.04 M | 100.00% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 11/13/2026 | 973.19 K | $1.01 M | -2.77% | 0.52% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/16/2026 | 901.30 K | $937.35 K | 1,503.74% | 0.48% |
| ROYCE & ASSOCIATES LP | 11/09/2026 | 888.39 K | $923.93 K | -33.54% | 0.48% |
| DIMENSIONAL FUND ADVISORS LP | 11/04/2026 | 855.72 K | $890.77 K | 58.12% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/16/2026 | 775.92 K | $806.96 K | 151.68% | 0.42% |
| KVP CAPITAL ADVISORS, LP | 11/16/2026 | 771.00 K | $801.84 K | 0.00% | 0.41% |
| TWO SIGMA INVESTMENTS, LP | 11/16/2026 | 769.44 K | $800.22 K | 140.22% | 0.41% |
| CM MANAGEMENT, LLC | 11/12/2026 | 750.00 K | $780.00 K | 36.36% | 0.40% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 11/16/2026 | 700.00 K | $728.00 K | 0.00% | 0.37% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/10/2026 | 677.25 K | $704.34 K | 29.30% | 0.36% |
| QUADRATURE CAPITAL LTD | 11/13/2026 | 638.82 K | $664.37 K | 490.13% | 0.34% |
| CITIGROUP INC | 11/04/2026 | 615.14 K | $639.74 K | -13.84% | 0.33% |
| EXOME ASSET MANAGEMENT LLC | 11/16/2026 | 511.08 K | $531.53 K | 85.06% | 0.27% |
| WALLEYE CAPITAL LLC | 11/13/2026 | 492.91 K | $512.63 K | 100.00% | 0.26% |
| BANK OF AMERICA CORP /DE/ | 11/16/2026 | 464.38 K | $482.96 K | -18.09% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/16/2026 | 459.04 K | $477.40 K | 21.22% | 0.25% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/16/2026 | 449.30 K | $467.27 K | 100.00% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/16/2026 | 430.89 K | $448.13 K | 42.14% | 0.23% |
Compass Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 239 institutional investors and hedge funds held shares of Compass Therapeutics Inc. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 17.99 M
ORBIMED ADVISORS LLC: 15.22 M
MONTANOVA CAPITAL, LLC: 14.33 M
BlackRock, Inc.: 11.39 M
Enavate Sciences GP, LLC: 7.79 M
STATE STREET CORP: 7.74 M
85.86% of Compass Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 179.97 M shares in the last 24 months. This purchase volume represents approximately $122.38 M in transactions.